Effect of a Single Dose of Cranberry Beverage on Inflammation and Oxidative Stress
NCT ID: NCT01780922
Last Updated: 2014-07-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2010-07-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Chronic Consumption of a Cranberry Beverage on Inflammation and Oxidative Stress
NCT01527617
Cranberry Enhances Human Immune Function and Reduces Illness
NCT01398150
Cranberry Ingestion and Cycling Related Immunity and Inflammation
NCT05407701
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
NCT03957239
Effects of Cranberry Juice on Cardiovascular Risk Factors
NCT02556749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Calorie Cranberry Juice Cocktail
Beverage containing cranberry: one dose of 15.2 ounces consumed within 15 minutes
Low Calorie Cranberry Juice Cocktail
Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes
Cranberry Extract Beverage
Beverage containing cranberry: one dose of 15.2 ounces consumed within 15 minutes
Cranberry Extract Beverage
Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes
Non-Cranberry Beverage
Beverage absent cranberry: one dose of 15.2 ounces consumed within 15 minutes
Non-Cranberry Beverage
Beverage absent cranberry at a dose of 15.2 ounces consumed within 15 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Calorie Cranberry Juice Cocktail
Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes
Cranberry Extract Beverage
Beverage containing cranberry at a dose of 15.2 ounces consumed within 15 minutes
Non-Cranberry Beverage
Beverage absent cranberry at a dose of 15.2 ounces consumed within 15 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI: 19-25 kg/m2
Exclusion Criteria
* Had major gastrointestinal surgery or on prescription or surgical treatment
* Any condition that may interfere with the digestion, absorption, metabolism or excretion of nutrients
* Regularly smoked in the previous 6 months
* On medication or ingested a prescribed drug at any time within the 14 days preceding study enrolment (excluding hormonal contraceptives and hormone replacement therapy) or over-the-counter preparation within 7 days preceding enrolment
* Risk factors for AIDS or known HIV positive status
* Pregnant or lactating
* High intake of chocolate or similar high polyphenol foods
* Regular intake of vitamin and polyphenol supplements
* Drug and alcohol misuse
* Currently participating or had participated in another clinical study during the previous 3 weeks
* Donated blood in the previous 3 weeks
* Exercise more than 3 times/week for longer than 45 min each time
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ocean Spray Cranberries, Inc.
INDUSTRY
Washington State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boon P Chew, PhD
Role: PRINCIPAL_INVESTIGATOR
Washington State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WSU Bioactives Research Lab
Pullman, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11369
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.